Novo Nordisk launches national Wevogy campaign

Novo Nordisk launched The Power of Wegovy, a new national campaign. The campaign aims to educate on the clinical data of Wegovy 2.4 mg injection and reflect the collective empowerment people living with obesity can feel when they don’t have to manage their weight alone. “Diverse representation in health care campaigns can play a significant role in patients feeling seen, heard and understood, especially in a stigmatized space like obesity, which we’ve been engaged in for more than two decades,” said Tejal Vishalpura, Senior Vice President, Commercial Strategy and Marketing for Novo Nordisk. “The Power of Wegovy is committed to representing a cross section of unique perspectives at this cultural inflection point in society, especially when the connection between obesity, cardiovascular risk, and the importance of patient-centered care is so much a part of the public discourse.”